GGrantIndex
Sort

8,912 grants matching sars cov 2

EAGER: Collaborative Research: Detection and Analysis of Airborne Coronavirus with Bioinspired Membranes

$154,057
Caitlin Howell · University Of Maine · · FY2020 · ENG

COVID-19, Social Distancing, and Cognitive Impairment in 1Florida ADRC participants

$154,001
Todd E. Golde · University Of Florida · P30 · FY2020 · AG

Targeting macrophages to reduce the combined injury effects of radiation and virus exposure

$154,000
Brian Marples · University Of Rochester · R21 · FY2023 · AI

Novel animal models to dissect how lung macrophages contribute to SARS-CoV2 alveolar pathology and respiratory failure

$153,630
David W Gludish · Cornell University · K01 · FY2025 · OD

Novel animal models to dissect how lung macrophages contribute to SARS-CoV2 alveolar pathology and respiratory failure

$153,630
David W Gludish · Cornell University · K01 · FY2023 · OD

Novel animal models to dissect how lung macrophages contribute to SARS-CoV2 alveolar pathology and respiratory failure

$153,630
David W Gludish · Cornell University · K01 · FY2024 · OD

CK22-008 Healthcare Modeling Workforce Development Through Washington State University's Resistance Epidemiology Modeling Initiative

$153,623
Eric T Lofgren · Washington State University · U01 · FY2023 · CK

Immune Dysfunction in HIV + Opiod Users

$153,500
Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2021 · DA

Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV

$153,500
Sabita Roy · University Of Miami School Of Medicine · R01 · FY2022 · DA

Role of Gut Microbiome- Brain Axis in Modulating CNS Inflammasomes in the Neuropathology Produced by Opioid Exposure and HIV

$153,500
Sabita Roy · University Of Miami School Of Medicine · R01 · FY2021 · DA

Immune Dysfunction in HIV + Opiod Users

$153,500
Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2022 · DA

Per- and Polyfluoroalkyl Substances (PFAS) Exposures and COVID-19 Vaccine Effectiveness

$153,500
Jefferey L Burgess · University Of Arizona · R21 · FY2022 · ES

Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens

$153,495
Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

The cost of illness: The impact of COVID-19 on patient financial outcomes

$153,360
Nora V. Becker · University Of Michigan At Ann Arbor · K08 · FY2024 · HS

Identification of Host-Specific Determinants of APOL1-associated COVAN

$153,306
Sarah Nystrom · Duke University · K08 · FY2024 · DK

Identification of Host-Specific Determinants of APOL1-associated COVAN

$153,306
Sarah Nystrom · Duke University · K08 · FY2025 · DK

Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19)

$153,089
Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Targeting polyamines to suppress SARS-CoV-2 related disease

$153,040
Natalia A Ignatenko · University Of Arizona · UH3 · FY2023 · TR

Integrated Metagenomic and Metatranscriptomic Characterization of Inflammatory Chronic Rhinosinusitis Endotypes

$153,029
Justin H Turner · Vanderbilt University Medical Center · R21 · FY2021 · AI

Collaborative Research: RAPID: Wastewater Informed Epidemiological Monitoring of SARS-CoV-2

$153,027
Kyle Bibby · University Of Notre Dame · · FY2020 · ENG

Methamphetamine Use and HIV as Risk Factors for COVID-19

$152,977
Adam Wayne Carrico · University Of Miami School Of Medicine · R01 · FY2020 · DA

The cost of illness: The impact of COVID-19 on patient financial outcomes

$152,960
Nora V. Becker · University Of Michigan At Ann Arbor · K08 · FY2023 · HS

Changing Talk Online Training (CHATO): A National Trial to Reduce Behavioral Symptoms in Long Term Care Residents with Alzheimer's Disease and Other Dementias

$152,871
Kristine N Williams · University Of Kansas Medical Center · R01 · FY2021 · AG

NA-ACCORD COVID-19 Supplment

$152,652
Richard Douglas Moore · Johns Hopkins University · U01 · FY2020 · AI

The cost of illness: The impact of COVID-19 on patient financial outcomes

$152,640
Nora V. Becker · University Of Michigan At Ann Arbor · K08 · FY2022 · HS